Hawk Ridge Capital Management LP Vanda Pharmaceuticals Inc. Transaction History

Hawk Ridge Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $2.72 Million - $3.84 Million	-203,600 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $3.58 Million - $6.32 Million	203,600 New	203,600 $3.75 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $4.91 Million - $8.15 Million	-258,877 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $3.64 Million - $5.23 Million	258,877 New	258,877 $4.36 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $270M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Hawk Ridge Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hawk Ridge Capital Management LP with notifications on news.